J. Yang

Neutrophil-to-lymphocyte ratio enhances mortality prediction beyond c-reactive protein in metabolic syndrome: a multi-cohort study

Systemic inflammation is a key driver of cardiovascular risk in metabolic syndrome (MetS). Although C-reactive protein (CRP) is widely used, its prognostic value may be enhanced by cellular immune markers such as the neutrophil-to-lymphocyte ratio (NLR), which integrates innate and adaptive inflammatory pathways....